Latest News
Conference Coverage
Causal AI quantifies CV risk, providing patient-specific goals
Causal artificial intelligence is showing how specific risk factors can be overcome to avoid cardiovascular events.
From the Journals
Biomarkers linked to elevated T2D MACE risk in DECLARE-TIMI 58
A secondary DECLARE-TIMI 58 trial analysis linked two biomarkers to higher cardiovascular risks in diabetes and found a strong benefit of...
Conference Coverage
NUDGE-FLU: Electronic ‘nudges’ boost flu shot uptake in seniors
Two strategies based on electronically delivered letters or “nudges” were found to increase flu shot uptake, compared with usual care, a new study...
Conference Coverage
EHR alerts boosted MRA prescribing to patients with HFrEF
Conference Coverage
BIOVASC: Immediate complete revascularization beneficial in ACS
Immediate complete revascularization during the index procedure might become the new treatment paradigm in patients with ACS and multivessel...
Conference Coverage
When intravascular imaging guides complex PCI, MACE risk is lowered
In stent placement for complex coronary lesions, intravascular imaging reduces events relative to angiography.
Conference Coverage
Viability-guided PCI doubted in stable severe CAD: REVIVED-BCIS2
Is myocardial viability testing for guiding PCI decisions currently used in the best way? A secondary analysis from the main trial suggests not....
Conference Coverage
Atorvastatin cut anthracycline cardiac dysfunction in lymphoma
Conference Coverage
Bempedoic acid cuts CV events in statin-intolerant patients: CLEAR Outcomes
The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL cholesterol–lowering therapies, experts say...
Conference Coverage
Transcatheter tricuspid valve repair effective and safe for regurgitation
In a randomized pivotal trial, a percutaneous repair of tricuspid valve regurgitation was effective and safe.
Conference Coverage
At 5 years, TAVI valves perform better than surgical ones
TAVR valves deteriorate less than surgical valves at 5 years in patients treated for severe aortic stenosis.